Dupont and Seegene to jointly develop highly multiplexed assays for food safety testing
In our previous blog post, we discussed the evolution of pathogen testing for food safety and the increasing need for multiplexing to be able to analyze for more than one pathogen at a time.
The vast majority of diagnostic companies participating in food safety pathogen testing currently provide single analyte solutions. Pall’s GeneDisk is one of the few offerings well suited to multiplex analysis.
As a further indication of the changing market, DuPont and Seegene announced on Thursday they will begin working jointly to develop new, highly multiplexed assays for foodborne pathogen detection. Seegene is a leading developer of multiplex molecular technologies and multiplex clinical molecular diagnostics.
By leveraging these novel technologies, we can advance from the current ‘one test, one pathogen’ approach to a ‘one test, many pathogens’ paradigm.
As pointed out by Seegene founder and CEO, Jong-Yoon Chun, “By leveraging these novel technologies, we can advance from the current ‘one test, one pathogen’ approach to a ‘one test, many pathogens’ paradigm.”
It will be interesting to watch how well the market adopts these multiplexing solutions and as a result, how the other diagnostic companies respond.